Triglyceride Glucose Index is Related with the Risk of Mild Cognitive Impairment in Type 2 Diabetes
Xue-Wei Tong,Yi-Tong Zhang,Zi-Wei Yu,Sheng-Dan Pu,Xin Li,Yu-Xin Xu,Yong-Yan Shan,Xin-Yuan Gao
DOI: https://doi.org/10.2147/DMSO.S389327
2022-11-18
Abstract:Xue-Wei Tong, Yi-Tong Zhang, Zi-Wei Yu, Sheng-Dan Pu, Xin Li, Yu-Xin Xu, Yong-Yan Shan, Xin-Yuan Gao First Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China Correspondence: Xin-Yuan Gao, Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang, People's Republic of China, Tel +86-18846030512, Email Background: The triglyceride glucose (TyG) index reflects insulin resistance; the latter being associated with mild cognitive impairment (MCI). Objective: To investigate the clinical value of the TyG index to identify MCI in patients living with type 2 diabetes (T2D) using a cross-sectional study. Methods: This cross-sectional study was performed on 517 patients with T2D. The diagnosis of MCI was based on criteria established by the National Institute on Aging-Alzheimer's Association workgroup, and patients were divided into the MCI group and the normal cognitive function (NCF) group. The logistic regression analysis determines whether the TyG index is related to MCI. Subsequently, we constructed the receiver operating characteristic curve (ROC) and calculated the area under the curve (AUC). The nomogram model of the influence factor was established and verified. Results: Compared to the type 2 diabetes-normal cognitive function (T2D-NCF) group, the MCI subjects were olderand had higher TyG indexes, lower cognitive scores, and lower education levels (p < 0.01). After adjusting for the confounders, the TyG index was associated with MCI (OR = 7.37, 95% CI = 4.72– 11.50, p < 0.01), and TyG-BMI was also associated with MCI (OR = 1.02, 95% CI = 1.01– 1.02, p< 0.01). The TyG index AUC was 0.79 (95% CI = 0.76– 0.83). The consistency index of the nomogram was 0. 83[95% CI (0. 79, 0. 86)]. Conclusion: Our results indicate that the TyG index and TyG-BMI are associated with MCI in T2D patients, and the TyG index is an excellent indicator of the risk of MCI in T2D patients. The nomogram incorporating the TyG index is useful to predict MCI risk in patients with T2D. Keywords: triglyceride glucose index, TyG, mild cognitive impairment, MCI, insulin resistance, IR, type 2 diabetes, T2D The incidence rate of diabetes has increased significantly in almost every country over the past few decades and is likely to increase further, making its complications a major public health problem. 1,2 With the attention paid to the quality of life of diabetes patients, cognitive dysfunction in diabetes has attracted more attention. A recent retrospective meta-analysis from China showed that the estimated prevalence of mild cognitive impairment in T2D patients reached 45%. 3 Compared to non-diabetic patients, the T2D patients had an average 0.3–0.4SDs reduction in the cognitive ability of memory, processing speed, and executive function. 4,5 A prospective meta-study showed that the risk of dementia in patients with diabetes increased by 73%, the risk of Alzheimer's disease (AD) increased by 56%, and the risk of vascular dementia (VAD) increased by 127%. 6 Throughout the screening, the newly discovered T2D patients, impaired fasting glucose patients, and metabolic syndrome patients have decreased in the same cognitive domains as patients with T2D. Therefore, it is speculated that the process of cognitive dysfunction starts at the early stage of diabetes and progresses over time. 7–9 In addition, we also know that patients with diabetes have an increased risk of dementia and a transition from mild cognitive impairment (MCI) to dementia. Therefore, it is very important to identify high-risk people with cognitive decline at an early stage. 2 Although the mechanism of cognitive dysfunction in diabetic people is not well understood, the mechanism of insulin resistance has been recognized by most scholars. 10,11 For nearly 40 years, the euglycemic-hyperinsulinemic clamp has always been the gold standard for measuring human insulin sensitivity. 12 However, the application of the euglycemic-hyperinsulinemic clamp is complicated, time-consuming, and laborious, with poor experience and high cost, so it is not suitable for the detection of insulin sensitivity in a large population. Therefore, low-cost and readily available alternative indicators of insulin sensitivity need to be developed. For the past few decades, insulin resistance has been measured mainly by the homeostasis model insulin resistance index (HOMA-IR). 13 Recently, some researchers have proposed to calculate the TyG index using the products of fasting triglycerides and blood glucose values. Compared with the euglycemic-hyperinsulinemic clamp, the TyG index has high sensitivity and specificity -Abstract Truncated-
endocrinology & metabolism